Biotech Investors & VC Firms
2475 firms in this list, with a median first check of $500K. 505 of them lead rounds. Generated from verified public data and updated continuously.
Embryo Ventures
LondonPre-Seed–Series A
2 people
Health Technology Holding (HTH)
Pre-Seed–Series B$500K – $1M
2 people
London & Scottish Investment Partners
EdinburghGrowth$130K – $320K
2 people
ScienceVest
New YorkPre-Seed–Seed$125K
2 people
UNIIQ
The HaguePre-Seed–Seed
1 person
Thuja Capital
UtrechtSeed–Series B
7 people
Abbhi Capital
MiamiSeed–Late Stage
Braidwell
Stamford
9 people
Byers Capital
Kültepe Investment
KayseriSeed
Mystic Ventures
LynnwoodPre-Seed–Series A
3 people
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
3 people
Unconventional Ventures
CopenhagenPre-Seed–Series A
3 people
Worthwhile Industries Campuses
TorontoLate Stage
Skolkovo Foundation
MoscowPre-Seed–Seed
5 people
TAYA Venture Capital
New Taipei CityPre-Seed–Growth
5 people
Lichen Ventures
BaltimoreSeed$200K
2 people
SNR VC
SeattlePre-Seed–Seed
2 people
Stake Capital
Pre-Seed–Series A
2 people
Arkin Digital Health
Seed–Late Stage
1 person
Healthspan Capital
OxfordSeed–Series A$5K
1 person
Markovian
Pre-Seed–Seed$50K
1 person
Metrodora Ventures
New York
1 person
Northspring Capital Partners
CambridgeGrowth
1 person
Related lists
Investors & VC Firms in North America (12835)Investors & VC Firms in United States (11883)Investors & VC Firms in Europe (5830)Investors & VC Firms in Global (4736)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4222)Healthtech Investors & VC Firms (4190)Enterprise Software Investors & VC Firms (4099)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.




































